Press Release
Please find enclosed press release for the financial results for the quarter ended June 30, 2017. Please take the above on record.29-07-2017
29-07-2017
Unaudited Financial Results For The Quarter Ended June 30, 2017
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the unaudited financial results for the quarter ended June 30, 2017, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 12:00 noon and concluded at 3:15 p.m....29-07-2017
Fixes Book Closure for Dividend & AGM (Cut-off date for e-voting)
Pfizer Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 24, 2017 to August 30, 2017 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company to be held on August 30, 2017.The Dividend, if approved by the members at the ensuing Annual General Meeting will be paid on September 14, 2017.27-07-2017
Annual General Meeting And Book Closure Notice - Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
This is to inform you that the Annual General Meeting of the Company is scheduled to be held on Wednesday, August 30, 2017 at 3:00 p.m. at Yashwantrao Chavan Pratishthan Auditorium, General Jagannath Bhosale Marg, Next to Sachivalaya Gymkhana, Mumbai 400 021. This is to inform you that the Register of Members and the Share Transfer Books of the Company will remain closed from Thursday, August 24, 2017 to Wednesday, August 30, 2017...26-07-2017
Board Meeting For The Unaudited Financial Results For The First Quarter Ended June 30, 2017 And Intimation Of Closure Of Trading Window.
This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, July 29, 2017, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the first quarter ended June 30, 2017. Please be informed that the Trading Window for trading in the Equity shares of the Company will be closed from July 20, 2017 to July 31, 2017, both days inclusive. We request you to kindly take the same on record.19-07-2017
Shareholding for the Period Ended June 30, 2017
Pfizer Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here12-07-2017
Statement Of Investor Complaints - Regulation 13 Of The SEBI (LODR) Regulations 2015 - June 30, 2017
Statement of Investor Complaints - Regulation 13 of the SEBI (LODR) Regulations 2015 - June 30, 201712-07-2017
Pfizer Jumps Over 7% On AstraZeneca Deal
Pfizer entered into a pact with AstraZeneca AB to acquire the 'Neksium' brand in India for Rs 75 crore.01-06-2017
Updates
This is to inform you that the Company has entered into an Acquisition Agreement with AstraZeneca AB, Sweden ('AstraZeneca'), pursuant to which the brand 'Neksium' is being acquired by the Company in India for a consideration of Rs. 75 Crores, subject to completion of necessary conditions precedent. Neksium (esomeprazole) complements the Company's existing product portfolio in the gastrointestinal (GI) therapeutic area. We request you to kindly take the above on record.31-05-2017
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations')
Pursuant to Regulation 30 of the Listing Regulations, please find attached details of the meeting scheduled with an Analyst/Institutional Investor. Please note that the above schedule is subject to change on account of exigencies on the part of the Analyst/Institutional Investor or the Company. This schedule shall also be displayed on the website of the Company - www.pfizerindia.com in compliance with the Regulation 46 of the Listing Regulations.29-05-2017